September 2026
The neurological biomarkers market size reached USD 11.66 billion in 2026 and is projected to surpass around 34.02 billion by 2035, with a solid CAGR of 12.67%.
September 2026
The circulating biomarkers market size reached USD 5.78 billion in 2026, with leading circulating biomarkers market companies including Abbott Laboratories, Becton, Dickinson and Company.
September 2026
The global cancer biomarkers market size was estimated at USD 17.49 billion in 2026 and is projected to hit around USD 47.14 billion by 2035 with a CAGR of 11.71%.
September 2026
The global proteomic biomarkers market size is growing as advanced proteomics enhances disease diagnosis, prognosis, and personalized therapy.
September 2026
The global veterinary biomarkers market size is estimated to hit around USD 4.13 billion by 2035 increasing from USD 1.40 billion in 2026, with a CAGR of 12.79%.
September 2026
The global digital biomarkers market size calculated at USD 6.19 billion in 2026 and is projected to hit around USD 36.98 billion by 2035 with a CAGR of 22.05%.
September 2026
The orphan disease biomarkers market expands with advancements in genomics, proteomics, and bioinformatics for rare conditions.
September 2026
The global predictive biomarkers market size is valued at USD 34.32 billion in 2026 and is predicted to hit around USD 155.53 billion by 2035, at a CAGR of 18.34%.
September 2026
The global biomarkers market size was valued at USD 107.90 billion in 2026 and is expected to hit around USD 355.72 billion by 2035 with a CAGR of 14.21%.
September 2026
The cns biomarkers market size was USD 8.81 billion in 2026, with leading cns biomarkers market players including F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Bio-Rad Laboratories, Quanterix Corporation.
September 2026
The parkinsons disease biomarkers market size reached USD 1.54 billion in 2026, with leading parkinsons disease biomarkers market companies including F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Thermo Fisher Scientific, Abbott Laboratories.
September 2026
The autoimmune neurological disorders market generated USD 9.17 billion in 2026, with prominent autoimmune neurological disorders market companies including Biogen Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Sanofi S.A.
September 2026
The stem cell therapy for neurological disorders market generated USD 17.90 billion in 2026, with prominent stem cell therapy for neurological disorders market companies including BrainStorm Cell Therapeutics, Mesoblast, ReNeuron Group.
September 2026
The global remote neurological monitoring market size was evaluated at USD 2.81 billion in 2026 and is predicted to hit around USD 9.69 billion by 2035, growing at a CAGR of 14.80%.
September 2026
The global cardiac biomarkers market size reached USD 27.86 billion in 2026 and is projected to surpass around USD 82.99 billion by 2034, with a remarkable CAGR of 14.62%.
June 2026
The global neurological rare disease biologics market is growing as advanced biologics address unmet needs in rare neurological disorders.
January 2026
The global personalized medicine biomarkers market size is projected to hit around USD 92.22 billion by 2035 from USD 22.04 billion in 2025 with a CAGR of 15.39%.
August 2025
The renal biomarkers market size was evaluated at USD 1.62 billion in 2024 and is projected to attain around USD 3.57 billion by 2034, with a solid CAGR of 8.22%.
August 2025
The neurotech devices market size was valued at USD 14.75 billion in 2024 and is projected to worth around USD 55.79 billion by 2034 with a CAGR of 13.84%.
July 2025
The global in-vitro inflammatory bowel disease diagnostics market size was valued at USD 1.74 billion in 2024 and is expected to hit around USD 3.02 billion by 2034, at a CAGR of 5.64%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com